IrisVision, Inc

PLEASANTON, CA · Founded 2017 · Medtech · Private

Wearable electronic low vision aid with head-mounted display for vision enhancement

Claim this profile

Follows are private to you and power your alerts

Updated · irisvision.com

Sector
Medtech
Headquarters
PLEASANTON, CA
Founded
2017
Latest Form D
$10M, Sep 2021
Total capital
$10M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$10M
1 Form D · last Sep 2021
61 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
15 pending · first 2019
Rank in peer group#286 of 1112

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $10M1st Form D$10M
2021FEDERAL ↑EQUITY ↓Cumulative $10M1st Form D$10M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$10M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#286 · top 26%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Frank WerblinResearcherDirectorLinked by 4 patents
  • Ammad KhanExecutive Officer, DirectorNamed in SEC Form D filings
  • Larry LeisureDirectorNamed in SEC Form D filings
  • Matthew JohnsonDirectorNamed in SEC Form D filings
  • Narendra MulaniDirectorNamed in SEC Form D filings
  • Syed Faiz AhmadDirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 21
Show all 21 patent records
  • Method and System for Remote Clinician Management of Head-Mounted Vision Assist DevicesDec 23, 2025 · US 12,504,810Granted
  • Methods and Apparatuses for Compensating for Retinitis PigmentosaMay 25, 2023 · Application 18057928Pending
  • Methods and Apparatus for Contrast Sensitivity CompensationMar 9, 2023 · Application 17931219Pending
  • Methods and Apparatuses for Compensating for Retinitis PigmentosaJan 3, 2023 · US 11,546,527Granted
  • Methods and Systems for Enabling the Remote Testing of Vision and Diagnosis of Vision-Related IssuesDec 15, 2022 · Application 17804366Pending
  • Methods and Apparatus for Contrast Sensitivity CompensationOct 18, 2022 · US 11,475,547Granted
  • Multi-modal Vision Enhancement SystemJun 28, 2022 · US 11,372,479Granted
  • Methods and Systems for Evaluating Vision Acuity and/or Conducting Visual Field Tests in a Head-Mounted Vision DeviceMay 26, 2022 · Application 17456490Pending
  • Clinician-modifiable Portable User Vision Enhancement SystemFeb 10, 2022 · Application 17445935Pending
  • Methods And Systems For Generating A Magnification Region In Output Video ImagesOct 12, 2021 · US 11,144,119Granted
  • Methods and Apparatus for Vision EnhancementOct 15, 2019 · US 10,444,833Granted
  • Method and System for Determining Vision Acuity in a Head-Mounted Vision DeviceApplication 63118538Pending
  • Methods And Systems For Evaluating Vision Acuity And/or Conducting Visual Field Tests In A Head-mounted Vision DeviceApplication PCTUS2021072593Pending
  • Methods And Apparatus For Compensating For Retinitis PigmentosaApplication PCTUS2020040726Pending
  • Multi-Modal Vision Enhancement SystemApplication 62990422Pending
  • Method And System For Remote Clinician Management Of Head-mounted Vision Assist DevicesApplication PCTUS2021072815Pending
  • Compensating for Retinitis Pigmentosa: Using dynamic shifts in field of view and magnificationApplication 62694173Pending
  • Methods and Apparatus for Low Vision EnhancementApplication 62629774Pending
  • Methods and Systems for Determining a Variety of Vision Parameters in a Head-Mounted Vision DeviceApplication 63223005Pending
  • Multi-modal Vision Enhancement SystemApplication PCTUS2021022491Pending
  • Method and System for Remote Management of Head-Mounted Vision Assist DevicesApplication 63122840Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .